1. |
Green RH,Brightling CE,McKenna S,et al. Asthma exacerbations and sputum eosinophil counts:a randomised controlled trial. Lancet,2002,360:1715-1721.
|
2. |
Peng T,Hao L,Madri JA,et al. Role of C5 in the development of airway inflammation,airway hyper-responsiveness,and ongoing airway response. J Clin Invest,2005,115:1590-1600.
|
3. |
Denning DW,O'Driscoll BR,Hogaboam CM,et al. The link between fungi and severe asthma:a summary of the evidence. Eur Respir J,2006,27:615-626.
|
4. |
Gao FS,Qiao JO,Jin XQ,et al. Chronic intranasal administration of Aspergillus fumigatus spores leads to aggravation of airway inflammation and remodeling in asthmatic rats. Respirology,2009,14:360-370.
|
5. |
龙飞,高福生,丁星,等. 烟曲霉菌提取物对人支气管上皮细胞粒-巨噬细胞刺激因子表达的影响. 第二军医大学学报,2008,29:917-920.
|
6. |
高福生,龙飞,祁卉卉,等. 吸入烟曲霉孢子对哮喘大鼠气道上皮重构和MUC5AC表达的影响. 上海交通大学学报:医学版,2008,28:1095-1099.
|
7. |
Wasylnka JA,Moore MM. Adhesion of Aspergillus species to extracellular matrix proteins:Evidence for involvement of negatively charged carbohydrates on the conidial surface. Infect Immun,2000,68:3377-3384.
|
8. |
Madan T,Priyadarsiny P,Vaid M,et al. Use of a synthetic peptide epitope of Asp f 1,a major allergen or antigen of Aspergillus fumigatus,for improved immunodiagnosis of allergic bronchopulmonary aspergillosis. Clin Diagn Lab Immunol,2004,11:552-558.
|
9. |
Kurup VP,Choi H,Murali PS,et al. IgE and eosinophil regulation in a murine model of allergic aspergillosis. J Leukoc Biol,1994,56:593-598.
|
10. |
Kauffman HF,Tomee JFC,Marjolein A,et al. Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol,2000,105:1185-1193.
|
11. |
张志红,Kauffman HF,Noordhoek J,等.烟曲霉菌对呼吸道上皮细胞的作用.安徽医科大学学报,2005,40:334-337.
|
12. |
王妍,龙飞,祁卉卉,等. 烟曲霉菌孢子对哮喘大鼠气道炎症和气道反应性的影响.中国呼吸与危重监护杂志,2007,6:185-196.
|
13. |
Foster PS,Rosenberg HF,Asquith KL,et al. Targeting eosinophils in asthma. Curr Mol Med,2008,8:585-590.
|
14. |
Egan RW,Umland SP,Cuss FM,et al. Biology of interleukin-5 and its relevance to allergic disease. Allergy,1996,51:71-81.
|
15. |
Leckie MJ,Brinke A,Khan J,et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils,airway hyper-responsiveness and the late asthmatic response. Lancet,2000,356:2144-2148.
|
16. |
Flood-Page PT,Menzies-Gow AN,KayAB,et al. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med,2003,167:199-204.
|
17. |
Flood-Page P,Swenson C,Faiferman I,et al. International Mepolizumab StudyGroup. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am J Respir Crit Care Med,2007,176:1062-1071.
|
18. |
Williams DL. Overview of (1-->3)-beta-D-glucan immunobiology. Mediators Inflamm,1997,6:247-250.
|
19. |
Agarwal R,Khan A,Aggarwal AN,et al. Clinical relevance of peripheral blood eosinophil count in allergic bronchopulmonary aspergillosis.J Infect Public Health,2011,4:235-243.
|
20. |
Greenberger PA.Chapter 18:Allergic bronchopulmonary aspergillosis. Allergy Asthma Pro,2012,33 Suppl 1:S61-S63.
|